Dr. Wassim Kassouf
- 笔谤辞蹿别蝉蝉辞谤,听
- Stephen Jarislowsky Chair in Urology聽
- Head, Urologic Oncology聽
- Associate Member, Pathology聽
MD, CM, FRCSC聽
Currently supervising students
Radiosensitization for invasive bladder cancer, both in preclinical and clinical settings聽
I am a surgeon-scientist who conducts both clinical and translational research in genitourinary cancers. My laboratory has focused on optimizing bladder-preserving therapies in patients with bladder cancer. We have developed expertise in radiosensitization for invasive bladder cancer, both in preclinical and clinical settings. Bringing novel basic science to clinic and then back has been an approach that our team continues to pursue. Findings from my laboratory have directly translated into four investigator-initiated clinical trials and I currently serve as study chair on the large, potentially practice-changing, randomized clinical trial evaluating radiation with immune checkpoint inhibition in bladder cancer that is activated in Canada, the UK and Spain.聽
- Urologic Oncology (bladder, kidney, prostate, testes, penile cancer)聽
- Robotic, laparoscopic, and open surgery聽
Cancer, GU聽
Dr Wassim Kassouf completed a fellowship in urologic oncology at M. D. Anderson Cancer Center in Houston, Texas following medical school and urology residency at McGill University. Dr. Kassouf鈥檚 clinical practice focuses on all aspects of urologic oncology (including bladder, prostate, renal, testes, and penile cancer) whereas his clinical and translational research program focuses on refining organ preservation approaches in bladder cancer. He is a Professor in the Division of Urology and past Vice-Chair of academic affairs, for the Department of Surgery at McGill University. He has also served as urology program director for 6 years and was a member of the Royal College Examination board committee.聽
He has led several national guidelines for optimizing quality of care in urologic cancer management and has published over 370 peer-review manuscripts and book chapters. His research is supported by independent peer-reviewed grant funding from the US Dept of Defense, CRS, and CIHR. He is bladder cancer section editor for CUAJ and has served as associate editor for BMC Urology, and is/has been on the editorial board of Urology, Clinical Cancer Investigation Journal, and International Brazilian Journal of Urology. He is a cofounder of Bladder Cancer Canada, GU co-chair of the Canadian Clinical Trials Group, and an executive member of the NIH Genitourinary steering committee Bladder Cancer Task Force. Dr Kassouf is a graduate of the AUA Leadership Program and received several prestigious awards including the American Urological Association Young Urologist of the Year, AUA Research Scholar Award, Quebec FRQS Distinguished Research Scholar Award, Bladder Cancer Canada Medical Leadership Award, and the Everett C. Reid Teaching Excellence Award.聽
